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 Abstract 
 
Rats reared in an enriched condition (EC) with novel stimuli and social contact with 
cohorts display less sensitization to nicotine than rats reared under impoverished 
conditions (IC).  However, it is currently unknown what effect differential rearing has on 
nicotine-induced conditioned hyperactivity.  The present study determined whether 
differential rearing affects conditioning to a nicotine-associated context.  In addition, this 
study also examined the effects of mecamylamine, an antagonist to nicotinic 
acetylcholine receptors, on conditioned hyperactivity and sensitization.  This antagonistic 
drug has been shown to attenuate the locomotor effects of nicotine.  In the current study, 
EC, IC, and social condition (SC) rats were reared from 21 to 51 days of age before 
training for the acquisition of conditioned hyperactivity and sensitization.  Nicotine (0.4 
mg/kg) was administered prior to 1-h locomotor sessions.  Conditioned hyperactivity 
testing followed.  Rats then received 5 sessions of sensitization training followed by a 16-
day drug-free rest period before being tested for sensitization.  Mecamylamine (1.0 
mg/kg) was administered to rats prior to the conditioned hyperactivity test and 
sensitization test.  Nicotine treatment resulted in sensitization and conditioned 
hyperactivity in all differential rearing groups. EC rats displayed less locomotor activity 
in response to nicotine than both IC and SC rats.  Pretreatment with mecamylamine 
blocked the expression of conditioned hyperactivity in EC and SC rats and attenuated 
sensitization in all three rearing groups.  These findings suggest that environmental 
enrichment may alter nAChR binding during development and may be a protective factor 
in the initiation and relapse of smoking behavior. 
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 Effects of Mecamylamine on Nicotine-Induced Conditioned Hyperactivity and 
Sensitization in Differentially Reared Rats 
Substance abuse is a large problem in today’s society.  This challenging issue 
affects many facets of life including economic, relational, and individual well-being.  
Currently, many researchers are trying to identify the behavioral, genetic, and neural 
processes that contribute to drug addiction.  An increasing body of research focuses on 
individual differences that may predict vulnerability to drug abuse. These findings are 
being used to develop treatment programs that may facilitate cessation of drug use.  
Although there has been an abundant amount of attention centered on genetic factors 
responsible for individual differences to drug addiction, genetics only partially 
contributes to substance abuse.  Environmental factors also play a large role in drug use 
and dependence, resulting in a genotype-environment interaction (McGue, Lykken, & 
Iocono, 1996).   
One environmental factor that may influence an individual’s vulnerability to drug 
abuse is the amount of novel stimuli experienced during development.  A method used to 
study the effects of this environmental factor is the environmental enrichment paradigm 
(Renner & Rosenzweig, 1987).  In this paradigm, rats are reared in two distinctly 
different environmental contexts. The enriched condition (EC) consists of a group of rats 
(10-12) that are housed in a relatively large cage with novel objects and are handled by 
the experimenter daily.  Daily, half of the objects are replaced with new objects while the 
remaining items are rearranged into a novel configuration.  All objects are replaced 1-2 
times a week.  The impoverished condition (IC) consists of rats housed individually 
without any novel stimuli and are not handled throughout the rearing period.   
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Differential rearing has been shown to produce many behavioral and 
neurobiological changes in rats in as little as 4 days of rearing (Ferchmin, Eterovic, & 
Caputto, 1970).  Although past research has shown robust differences between rats raised 
in enrichment and impoverishment after 90 days of rearing, significant differences can 
still be found following 30 days (Cain, Green, & Bardo, 2006; Green, Cain, Thompson & 
Bardo, 2003; Renner & Rosenzweig, 1987).  Similarly, many researchers have examined 
the effects of age at which the differential rearing experience starts.  Neuronal changes 
have been observed in rats given differential housing starting from weaning age to 600 
days of age (Renner & Rosenzweig, 1987).   
Rats reared in enriched environments have been found to have greater brain 
weight (Huntley & Newton, 1972) and increased dendritic branching relative to 
impoverished rats (Greenough, Volkmar, & Juraska, 1973).  While a number of 
neurochemical changes also occur, of particular interest to drug abuse are the changes 
that occur in the dopamine (DA) and acetylcholine (ACh) neurotransmitter systems.  The 
mesolimbic DA reward system is critical for the reinforcing effects of nicotine 
(Laviolette & van der Kooy, 2004).  It has been suggested that exposure to novelty 
activates this system (Bardo, Donohew, & Harrington, 1996).  Although research to date 
has been inconclusive if EC and IC rats differ in baseline levels of DA in the nucleus 
accumbens (NAcc), EC rats have been shown to have increased DA release in the NAcc 
in response to amphetamine (Bowling & Bardo, 1994). Given that nicotine induces DA 
release in the NAcc (Laviolette & van der Kooy, 2004), it is reasonable to suggest that 
EC and IC rats would differ in DA release in response to nicotine administration. In 
addition to alterations in the DA system, increases in ACh have also been observed in rats 
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reared in enriched environments (Degroot, Wolff, & Nomikos, 2005).  This 
neurotransmitter has been found to be critical for the consolidation of long-term memory 
(Blokland, 1995). 
In conjunction with these neurobiological changes are the observed behavioral 
differences between rats reared in enriched and impoverished environments. For 
example, it has been shown that EC rats perform better than IC rats on spatial learning 
tasks. In one study, EC rats were observed to make the correct choice in a 17-radial arm 
maze more accurately and efficiently relative to their IC counterparts (Juraska, 
Henderson, & Muller, 1984).  EC rats have also been found to be more successful than IC 
rats in passive avoidance tasks (Freeman & Ray, 1972) and display increased contextual 
conditioning in signaled Pavlovian fear conditioning paradigms (Barbelivien et al., 2006; 
Woodcock & Richardson, 2000).  It is believed that this effect is due in part to improved 
memory and learning.  Environmental enrichment has also been shown to accelerate 
habituation to novel stimuli (Schrijiver, Bahr, Weiss & Wurbel, 2002; Zimmermann, 
Stauffacher, Langhans, & Wurbel, 2001) and decrease activity in an inescapable novel 
environment relative to IC rats (Bowling, Rowlett & Bardo, 1993; Green, et al., 2003).     
Since the development of this paradigm, it has been argued that social stimulation 
may solely be the cause of the observed differences found between EC and IC rats.  Thus, 
many researchers have included a third context (social condition; SC) in which rats are 
housed in pairs under standard laboratory conditions and are handled once a week during 
weekly bedding changes.  SC rats have been found to be between EC and IC rats in 
multiple brain measures, indicating that social stimulation alone is not responsible for the 
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observed differences between EC and IC rats (Rosenzweig, Bennett, Hebert, & 
Morimoto, 1978).   
Exposure to novel stimuli during development has been widely used to investigate 
the effects of rearing environment on the subsequent response to drugs of abuse such as 
amphetamine.  While EC rats self-administer less amphetamine at low unit doses (Bardo, 
Klebaur, Valone, & Deaton, 2001), they are more sensitive to the locomotor effects of 
acute amphetamine at both moderate (0.5 mg/kg) and high (2.0 mg/kg) doses (Bowling & 
Bardo, 1993), but not at low doses (0.1 or 0.3 mg/kg) (Bardo et al., 1995).  In contrast 
however, IC rats have been found to be more sensitive to the locomotor effects of chronic 
amphetamine administration at a low unit dose (0.3 mg/kg) (Bardo et al., 1995).  
Additionally, enrichment appears to increase the rewarding effects of amphetamine in 
conditioned place preference paradigms (CPP) (Bardo et al., 1995).  It is important to 
note the apparent contradiction that, although EC rats are less sensitive to repeated 
amphetamine administrations, they are more sensitive to amphetamine-induced CPP 
relative to IC rats.  It has been suggested that since EC rats are more sensitive to acute 
amphetamine, this initial sensitivity may be reflected in one-trial CPP (Bardo et al., 
1995).   
Alternatively, the enhanced CPP may be due to an enhanced ability to process 
contextual cues.  EC rats display greater contextual conditioning and are better at context 
discrimination relative to IC rats (Barbelivien et al., 2006; Woodcock & Richardson, 
2000). This would suggest that EC rats are also more sensitive to Pavlovian-conditioned 
drug cues.  Although much research has investigated the effects of differential rearing on 
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addictive drugs such as amphetamine and cocaine, one of the most commonly abused and 
addictive drugs, nicotine, has been sparsely investigated within this paradigm.  
Nicotine addiction is one of the most visible public health concerns today.  It is 
estimated that 20.9 % (45.1 million) adults in the United States currently smoke, 
contributing to an estimated 438,000 preventable deaths (Centers for Disease Control & 
Prevention, 2005a, 2005b).  Although nicotine is generally not considered to be one of 
the ‘harder’ addictive substances, with repeated exposure, it is often just as difficult to 
discontinue its use (Laviolette & van der Kooy, 2004).  
 Interestingly, very little is understood about how the rearing environment 
contributes to nicotine addiction, cessation, and relapse.  For example, why is it that some 
individuals can smoke a cigarette on occasion and never become addicted while others 
readily seek tobacco after their first encounter, leading to addiction? Or, why do some 
successfully quit smoking while others struggle to kick the habit? Understanding how the 
rearing environment contributes to these individual differences in drug abuse will aid in 
the development of prevention and cessation programs. 
Previous research has implicated associative learning, specifically Pavlovian 
conditioning processes, to play a role in the etiology of nicotine dependence (Koob & Le 
Moal, 2001; Rose, Behm, & Levin, 1993).  The procedure of Pavlovian conditioning 
refers to establishing a relationship between two events or stimuli.  One of these stimuli is 
a relatively neutral stimulus called the conditioned stimulus (CS) while the other is 
termed the unconditioned stimulus (US) and is more biologically significant.  The 
phenomenon of Pavlovian conditioning occurs when the CS elicits a response it did not 
before, indicating a learned association (Frieman, 2002; Pavlov, 1927).  Nicotine has 
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been found to stimulate contextual conditioning in rats (Belluzzi, Lee, Oliff, Leslie, 2004; 
Reid, Ho, Berger, 1996).  More specifically, conditioned-hyperactivity can be observed in 
rats that have had repeated nicotine administrations (US) paired with a distinct context 
(CS) (Bevins, Besheer, & Pickett, 2001; Bevins & Palmatier, 2003; Palmatier & Bevins, 
2002; Reid et al. 1996; Walter & Kuschinsky, 1989).  After repeated pairings, the context 
alone can come to produce an increase in activity relative to control rats.  This learned 
association is thought to partially mediate continued tobacco use and relapse by 
contributing to withdrawal effects and cravings (Lazev, Herzog, & Brandon, 1999; Rose 
et al., 1993).  
The effects of nicotine on locomotor activity in rats are quite complex and 
consists of a biphasic effect on activity (Clarke & Kumar, 1983; Stolerman, Fink, & 
Jarvik, 1973).  In non-tolerant rats, acute nicotine initially produces hypoactivity for 
roughly 15 min followed by a period of hyperactivity depending upon the dose and 
habituation to the testing apparatus. Rats that have habituated to the testing apparatus 
display less sensitivity to the depressant effects of nicotine. With repeated exposure to 
nicotine, sensitization develops to the hyperactivity.  Behavioral sensitization in response 
to nicotine can be observed following 5 days of nicotine treatment when tested on the 
sixth day and is reflected by an increase in locomotor activity (Benwell & Balfour, 1992; 
Clarke & Kumar, 1983; Walter & Kuschinsky, 1989).  In one previous study (Miller, 
Wilkins, Bardo, Crooks, & Dwoskin, 2001), rats were administered nicotine once a week 
for 6 weeks followed by a 21 day no drug period.  Interestingly, when given a nicotine 
challenge, rats still expressed behavioral sensitization.  This suggests that even occasional 
nicotine exposure may initiate neuroadaptive processes that contribute to addiction.   
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As mentioned previously, relatively few studies have investigated the effects of 
rearing environment on nicotine addiction.  Green et al., (2003) observed that EC rats 
pretreated with nicotine display less development of sensitization relative to IC and SC 
rats, suggesting that environmental enrichment produces decreased sensitivity to the 
stimulant effects of nicotine.  In this study, rats were pretreated with either a high dose 
(0.8 mg/kg) or low dose (0.2 mg/kg) of nicotine for 8 days and challenged with only the 
high dose of nicotine.  However, this study did not look at the effects of rearing 
environment on nicotine-induced conditioned hyperactivity.  In another study (Faraday, 
Scheufele, Rahman, & Grunberg, 1999), the effects of social rearing on nicotine-induced 
locomotor activity were examined.  The results of this study showed that rats housed 
individually displayed decreased locomotor activity in response to nicotine while rats 
housed in groups increased in locomotor activity, contradicting the results found by 
Green et al. (2003).  However, rats were not housed in their experimental condition until 
the start of drug administration and nicotine was administered continuously through 
osmotic mini-pumps whereas Green et al. (2003) administered nicotine subcutaneously.   
Research examining the physiological factors that influence nicotine dependence 
have found that nicotinic acetylcholine receptors (nAChRs) play a large role in mediating 
the effects of nicotine (Laviolette & van der Kooy, 2004; Matta, Fu, Valentine, & Sharp, 
1998).  Activation of nAChRs has been shown to contribute to the reinforcing effects of 
nicotine, acutely enhancing the release of dopamine in the NAcc (Benwell & Balfour, 
1992; Corrigall, Franklin, Coen, & Clarke, 1992).   Additionally, the effects of nicotine 
on attention, learning, and memory are believed to be partially mediated through these 
receptors (Blokland, 1995; Levin, McClernon, & Rezvani, 2006; Olausson, Jentsch, & 
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Taylor, 2004). Given this role of nAChRs, an abundant amount of research has 
investigated the effects of nAChR antagonists on the behavioral and physiological effects 
of nicotine.   
Mecamylamine is a nonselective nAChR antagonist that readily crosses the blood-
brain barrier (Clarke & Kumar, 1983). Its therapeutic potential in smoking cessation has 
been widely investigated using various paradigms.  Previous studies have shown that 
mecamylamine dose dependently decreases self-administration of nicotine in rats 
(Corrigall & Coen, 1989; Shoaib, Schindler, & Goldberg, 1997; Watkins, Epping-Jordan, 
Koob, & Markou, 1999), attenuates cue-induced reinstatement of nicotine-seeking 
behaviors (Liu et al., 2007), and blocks the rewarding effects of nicotine in conditioned 
place preference paradigms (Fudala, Teoh, & Iwamoto, 1985).  Although mecamylamine 
alone has not been found to alter the locomotor activity of rats, pretreatment with a 
moderate dose (1.0 mg/kg) has been shown to attenuate the acute and chronic effects of 
nicotine-induced locomotor activity (Clarke & Kumar, 1983; Neugebauer et al., 2006; 
Stolerman, Garcha, & Mirza, 1995).  When a low dose of mecamylamine is administered 
(0.1 mg/kg) nicotine-induced locomotor hypoactivity is blocked.  However, 
mecamylamine does not seem to attenuate the stimulant effects of chronic nicotine 
administration (Bevins & Besheer, 2000). 
Interestingly, few studies have examined how differential rearing may predict 
sensitivity to the antagonistic effects of drugs, such as mecamylamine, on nicotine-
induced locomotor activity.  Nicotine has been found to disrupt individual differences in 
locomotor activity in high and low responding rats (HR, LR) (Bevins & Besheer, 2001).  
HR rats display high amounts of activity when placed in an inescapable novel 
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environment while LR rats display low amounts of activity.  Mecamylamine was found to 
restore these individual differences, thus suggesting that the disruptive affects of nicotine 
on HR and LR rats is mediated by nAChRs.  Investigating these differences in sensitivity 
to receptor antagonism could potentially lead to identifying processes that mediate 
vulnerability to drug abuse. 
While it appears that enrichment may be a protective factor against drugs of abuse 
such as amphetamine, it is not clear if this environmental factor is also protective against 
nicotine addiction.  It is also unclear what neural mechanisms mediate the affects of 
differential rearing on the subsequent response to nicotine.  The current study examined 
the effects of repeated nicotine administration on locomotor activity in rats reared in 
enriched, social, and impoverished conditions.  In accordance with past research, it is 
hypothesized that EC rats will display less sensitization relative to SC and IC rats.  
Another goal of this study was to assess the effects of mecamylamine on conditioned 
hyperactivity and sensitization to nicotine in differentially reared rats.  Currently, very 
little is known about the effects of differential rearing on Pavlovian conditioned drug 
cues to nicotine and the role of nACh receptors in mediating these effects.  It is 
hypothesized that the nicotinic antagonist, mecamylamine, will attenuate both the 
hypoactive and stimulant effects of nicotine and, additionally, will decrease the 
expression of conditioned hyperactivity.  It is expected that this affect will be greatest in 
EC rats since they have been shown to have increases in ACh relative to IC rats (Degroot, 
Wolff, & Nomikos, 2005).  
If it is observed that differential rearing alters the behavioral response to nicotine, 
it will suggest that the rearing environment contributes to the individual differences found 
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in nicotine addiction, cessation, and relapse.  The observed effects of mecamylamine on 
conditioned-hyperactivity and sensitization will further our understanding of the neural 
processes that mediate vulnerability to drug abuse.   
Method 
Animals 
 
Male Sprague-Dawley rats (Charles River, Portage, MI, USA) were obtained at 
21 days of age.  Rats had access to food and water throughout the experiment.  The 
colony room was maintained at 24° C and 45% humidity with a 12 h light:dark cycle. 
Behavioral testing was conducted during the light portion of the cycle.  All procedures 
were approved by the Institutional Animal Care and Use Committee at Kansas State 
University and are in compliance with the Guide for the Care and Use of Laboratory 
Animals (1996). 
Drugs 
 S (–) -Nicotine ditartrate (0.4 mg/kg; Sigma, St. Louis, MO) and mecamylamine 
hydrochloride (1.0 mg/kg; Sigma, St. Louis, MO) was dissolved in 0.9% saline solution.  
Nicotine dose was calculated as freebase weight and adjusted to a pH of 7.4. Treatments 
were administered in a volume of 1 ml/kg subcutaneously.  Drug doses were chosen 
based on previous research (Green et al., 2003; Neugebauer et al., 2006).  
 
Apparatus
The locomotor chamber measures 40.64 x 40.64 x 40.64 cm.  The chamber 
consists of plexiglass walls and plastic flooring which was covered by pine bedding.  The 
photobeam sensor ring consists of a 16 x 16 (x-axis) photocell array.  These photocells 
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are spaced 2.54 cm apart (Coulbourn Instruments, TruScan 2.01) and linked to a personal 
computer.  The total distance traveled in centimeters was recorded.  Cumulative 
photobeam interruptions, in 5-min blocks of time, were also recorded within each 
session.  A white-noise generator (~70dB) was used to create ambient background noise 
to mask sounds from outside the chamber. 
Environmental Conditions 
 
Upon arrival, rats were randomly assigned to one of three conditions; EC (n = 34), 
SC (n = 34), or IC (n = 33).  Rats were housed in these conditions for the duration of the 
study. EC rats were housed together (10-14 rats) in a large metal cage (60 x 120 x 45 cm) 
with pulp paper bedding.  This environment contained 14 novel objects (i.e., PVC pipe, 
buckets, children’s toys, etc.).  Each day, rats were handled and 7 of the objects were 
replaced with 7 new objects; the remaining items were rearranged into a novel 
configuration.  One to two times a week, all objects were replaced with new items. SC 
rats were housed in pairs in standard laboratory cages (20 x 20 x 42 cm) with paper pulp 
bedding and a wire rack top. These rats were handled once a week during scheduled 
bedding changes in compliance with the Guide for the Care and Use of Laboratory 
Animals (1996).  IC rats were housed individually in hanging wire cages with a wire 
mesh floor and front panel (17 x 24 x 20 cm), and solid metal sides, back and top.  IC rats 
were not handled during their rearing period (21-51 days of age).  
Behavioral Procedures 
Acquisition of conditioned hyperactivity.  At 51 days of age, rats were randomly assigned 
to one of 3 groups: Paired (n = 38), Unpaired (n = 29), and Control (n = 34). All rats in 
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the Paired group received repeated pairings of the locomotor chamber (context CS) with 
the nicotine US. Thus, once every other day, rats in the Paired group were injected with 
nicotine subcutaneously immediately prior to a 1-h session.  On alternating days, rats 
received saline injections and remained in their home cage.  All rats in the Unpaired 
group were injected with saline prior to being placed in the locomotor chambers.  To 
control for repeated nicotine exposure, the Unpaired group was also administered 
nicotine in the home cage on the rest days.  The Control group received saline injects in 
both the locomotor environment and home cage.  Each group received a total of 10 
locomotor sessions and 10 home cage injections.  Following each 1-h locomotor session, 
rats were removed and returned to their home cage. 
Conditioned hyperactivity test. Following 10 acquisition sessions, all rats received two 
injections.  Rats were administered either mecamylamine (1.0 mg/kg; s.c.) (n = 53) or 
saline (n = 48) in the home cage 15-m prior to a saline injection in the locomotor room.  
Rats were placed into the locomotor chambers immediately following the second 
injection for 1-h.  
Sensitization training.  Following the conditioned hyperactivity test, all rats received 4 
additional sessions of conditioning (38 rats in the Paired condition, 28 in the Unpaired 
condition, and 34 rats in the Control condition).  During sensitization training, one IC rat 
became ill and thus, was excluded from the analysis. Procedures were identical to those 
described for acquisition of conditioned hyperactivity.  Following the last day of 
sensitization training, rats underwent a 16 day resting period. During this time, no home 
cage injections were administered. 
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Sensitization test.  Mecamylamine or saline was administered 15-m prior to a nicotine 
(0.4 mg/kg) challenge 16 days after nicotine pretreatment.  Mecamylamine (n = 47) and 
saline (n = 52) treatments were counterbalanced between rats from the conditioned-
hyperactivity test.  For the sensitization test, an additional IC rat became ill and thus, was 
excluded from the analyses. All rats were placed into the locomotor chambers 
immediately following the nicotine injection for 1-h.  
Data Analysis 
The total distance traveled in centimeters during acquisition and sensitization 
sessions was analyzed using a mixed-factorial analysis of variance (ANOVA) with 
rearing condition (EC, SC, IC) and nicotine treatment (Paired, Unpaired, Control) as 
between-subjects factors and sessions as within-subjects factors.  To examine differences 
between the rearing conditions in hypoactivity, a mixed-factorial ANOVA was 
performed with rearing condition and nicotine treatment as between-subjects factors and 
cumulative 5-min photobeam interruptions as within-subjects factors.  
The total distance traveled (cm) during the conditioned hyperactivity and 
sensitization test was analyzed using a between subjects ANOVA with rearing condition, 
nicotine treatment, and mecamylamine treatment as between subjects factors. The total 
distance traveled (cm) during the conditioned hyperactivity test and sensitization test was 
also converted into z-scores and analyzed using a 3 x 3 x 2 (rearing condition, nicotine 
treatment, mecamylamine treatment) between subjects ANOVA. To examine the effects 
of mecamylamine on the hypoactive effects of nicotine during the sensitization test, a 
mixed-factorial ANOVA was performed with rearing condition and mecamylamine 
treatement as between subjects factors and cumulative 5-min photobeam interruptions as 
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within-subjects factors.  The alpha level was set to .05 for all analyses. Bonferroni 
corrected simple effects were performed to probe the interactions.   
Results 
Acquisition of conditioned hyperactivity 
 
Repeated nicotine administration increased locomotor activity across sessions and 
differentially affected rearing groups.  For acquisition sessions, there was a significant 
main effect of session, F(9, 828) = 4.57, p<.001, a main effect of rearing condition, F(2, 
92) = 72.11, p<.001, a session X nicotine treatment interaction, F(18, 828) = 31.42, 
p<.001, a session X rearing condition interaction, F(18, 828) =  4.54, p<.001, and a 
rearing condition X nicotine treatment X session interaction , F(36, 828) = 1.97, p<.001 
(Figure 1).  Nicotine significantly increased locomotor activity in Paired groups. The IC-
Paired group significantly differed from IC-Controls on session 3-10, F’s(1, 92) = 15.72 
– 109.61, p’s<.001.  The SC-Paired group also significantly differed from SC-Controls 
on sessions 3-10, F’s(1, 92) = 26.58 – 78.08, p’s<.001.  The EC-Paired group 
significantly differed from EC-Controls on sessions 2-8 and 9-10, F’s(1, 92) = 13.19 – 
70.8, p’s<.001.   
In examining differences between rearing groups treated with nicotine, IC-Paired 
rats displayed significantly greater locomotor activity than EC-Paired rats on sessions 2-
10, F’s(1, 92) = 20.03 – 97.99, p’s<.001.  SC-Paired rats were observed to display 
significantly greater locomotor activity than EC-Paired rats on sessions 2-7, 9, and 10, 
F’s(1, 92) = 12.48 – 25.28, p’s<.001.  IC-Paired rats had significantly greater locomotor 
activity than SC-Paired rats only on day 9, F(1, 92) = 12.42, p<.001 and day 10, F(1, 92) 
= 22.27, p<.001 (Figure 2A).  Control groups were also found to significantly differ in 
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locomotor activity based on rearing condition, with IC- and SC-Control groups 
displaying greater activity than EC-Controls.  SC- and EC-Controls were found to differ 
on sessions 1-3, 5, 6, 9, and 10, F’s(1, 92) = 12.83 – 23.12, p’s<.001.  IC- and EC-
Control groups were also found to significantly differ on days 1-7, 9, and 10, F’s(1, 92) = 
18.58 – 47.00, p’s<.001 (Figure 2B). 
The biphasic effect of nicotine was examined between rearing groups.  There 
were no significant differences in hypoactivity or hyperactivity during session 1 of 
acquisition between EC-, SC-, and IC-Paired rats (Data no shown).  
Conditioned hyperactivity test 
When treated with saline, in substitute for nicotine, rats in the Paired groups 
displayed conditioned-hyperactivity relative to Control groups.  Main effects of rearing, 
F(2, 83) = 53.99, p<.001,  and nicotine treatment, F(2, 83) = 20.44, p<.001,  were found.  
When rats were pretreated with saline only prior to the session, rats in each rearing 
condition displayed conditioned-hyperactivity, with Paired groups displaying greater 
locomotor activity than Controls.  IC-Paired rats significantly differed from IC-Controls, 
F(1, 83) = 11.79, p<.001.  SC-Paired and SC-Control groups significantly differed, F(1, 
83) = 8.99, p<.01 and EC-Paired and EC-Control groups significantly differed, F(1, 83) = 
8.61, p<.01.  EC rats in the Paired group had significantly less locomotor activity than 
both SC-Paired, F(1, 83) = 8.62, p<.01 and IC-Paired groups, F(1, 83) = 27.00, p<.001. 
EC-Unpaired and rats were also found to display significantly less locomotor activity 
than IC-Unpaired rats, F(1, 83) = 18.41, p<.001.  In addition, differences in rearing 
groups between saline-treated Control rats were also found.  EC-Controls had 
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significantly less locomotor activity than both IC-Controls, F(1, 83) = 18.65, p<.001, and 
SC-Controls, F(1, 83) = 8.24, p<.01 (Figure 3A).    
 Pretreatment of mecamylamine was found to attenuate conditioned hyperactivity 
only in EC and SC rats (Figure 3B).  IC-Paired rats still displayed conditioned 
hyperactivity as they had significantly greater locomotor activity than IC-Unpaired, F(1, 
83) = 7.38, p<.01, and IC-Controls, F(1, 83) = 12.90, p<.001.   
In order to standardize the observed baseline differences in saline-treated Control 
rats, data from the conditioned-hyperactivity test were transformed into z-scores.  A main 
effect of injection was found, F(2, 83) = 18.71, p<.001.  EC, SC, and IC rats pretreated 
with saline in the Paired groups were still observed to display conditioned hyperactivity 
relative to Control groups, F(1, 83) = 7.43, p<.01, F(1, 83) = 9.29, p<.01, F(1, 83) = 9.70, 
p<.01 (Figure 4A).  Although there was no main effect of rearing, IC rats pretreated with 
mecamylamine were still observed to displayed conditioned hyperactivity relative to IC-
Controls, F(1, 83) = 7.24, p<.01, while EC and SC rats pretreated with mecamylamine 
did not display conditioned hyperactivity (Figure 4B).    
 Sensitization Training 
Across sensitization training sessions, rats in the Paired groups were observed to 
display increased locomotor activity (Figure 5).  Repeated measures revealed a 
significant session X nicotine injection interaction, F(6, 273) = 2.43, p<.05, a main effect 
of nicotine injection, F(2, 91) = 137.34, p<.001,  and a main effect of rearing condition, 
F(2, 91) = 71.22, p<.001.  EC, IC, and SC rats in the Paired groups were found to display 
significantly greater locomotor activity than both Unpaired and Control groups across all 
4 sessions of training, F’s(1, 91) = 35.22 – 94.68, p’s<.001.  IC rats in the Paired group 
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displayed significantly greater locomotor activity than SC-Paired rats only on day 4 of 
sensitization training, F(1, 91) = 20.05, p<.001.  However, EC-Paired rats had less 
locomotor activity than both SC-Paired, F’s(1, 91) = 17.64 – 28.56, p’s<.001, and IC-
Paired rats, F’s(1, 91) = 55.95 – 79.92, p’s<.001, on all 4 days of training (Figure 6A).    
EC-Controls had significantly less locomotor activity than SC-Controls only on sessions 
2, F(1, 91) = 23.32, p<.001, and 3, F(1, 91) = 13.00, p<.001.  However, EC-Controls 
displayed significantly less locomotor activity than IC-Controls across all 4 sensitization 
training sessions, F’s(1, 91) = 24.17 – 33.77, p’s<.001 (Figure 6B).  
Sensitization Test 
During sensitization testing, all rats were treated with nicotine.  Rats in the Paired 
groups were found to display significant sensitization to nicotine.  An overall main effect 
of rearing, F(2, 810) = 24.42, p<.001, and a main effect of nicotine treatment, F(2, 81) = 
34.82, p<.001, was found.  Also, a two-way interaction of nicotine treatment X 
mecamylamine treatment was observed, F(2, 81) = 5.28, p<.001.  For rats pretreated with 
saline only prior to the testing session, Paired groups in each rearing condition displayed 
sensitization.  IC-Paired rats significantly differed from IC-Controls, F(1, 81) = 32.98, 
p<.001.  SC-Paired rats significantly differed from SC-Controls, F(1, 81) = 20.32, 
p<.001, and EC-Paired rats were found to significantly differ from EC-Controls, F(1, 81) 
= 18.23, p<.001.  Additionally, EC-Unpaired rats significantly differed from EC-
Controls, F(1, 81) = 8.59, p<.01.  Comparisons between rearing conditions revealed that 
IC rats in the Paired group displayed significantly greater sensitization than EC-Paired 
rats, F(1, 81) = 7.72, p<.01 (Figure 7A). 
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When comparing mecamylamine pretreatment to saline pretreatment, rats in the 
Paired group treated with mecamylamine were found to display significantly less 
locomotor activity than rats treated with saline in the Paired group, regardless of rearing 
condition, F(1, 81) = 13.82, p<.001 (Figure 7B).   IC- and SC-Paired rats displayed 
significant sensitization relative to Controls, F(1, 81) = 4.23, p<.05, F(1, 81) = 5.97,  
p<.05 while EC-Paired rats only significantly differed from EC-Unpaired rats, F(1, 81) = 
4.17, p<.05.  Comparisons between rearing conditions revealed that EC-Paired rats had 
less locomotor activity than IC-Paired, F(1, 81) = 8.33, p<.01, and SC-Paired rats, F(1, 
81) = 11.67, p<.001.  Similarly, EC-Unpaired rats displayed significantly less locomotor 
activity than both IC-Unpaired, F(1, 81) = 11.92, p<.001, and SC-Unpaired rats, F(1, 81) 
= 7.71, p<.01.  EC-Control rats pretreated with mecamylamine were also found to have 
significantly less locomotor activity than IC-Controls, F(1, 81) = 10.81, p<.01 (Figure 
7C) 
When data from the sensitization test was transformed into z-scores, a main effect 
of injection was found, F(2, 81) = 36.82, p<.001.  However, there was no effect of 
rearing condition.  Rats in the Paired groups pretreated with saline only, were observed to 
display significant sensitization.  EC-Paired rats significantly differed from EC-Controls, 
F(1, 81) = 14.06, p<.001.  SC-Paired rats were found to significantly differ from SC-
Paired rats, F(1, 81) = 25.33, p<.001.  IC-Paired rats significantly differed from IC-
Controls, F(1, 81) = 13.39, p<.001 (Figure 8A).   
 Mecamylamine was found to attenuate expression of sensitization, however, it did 
not completely block sensitization. Z-score analyses revealed that EC-Paired rats had 
significantly greater locomotor activity than EC-Unpaired rats, F(1, 81) = 6.91, p<.01, 
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and EC-Controls, F(1, 81) = 4.54, p<.05.  Similarly, IC-Paired rats displayed 
sensitization relative to IC-Controls, F(1, 81) = 10.57, p<.01, and SC-Paired rats 
displayed sensitization relative to SC-Controls, F(1, 81) = 10.33, p<.01 (Figure 8B). 
 In order to examine the effects of mecamylamine on the hypoactive effects of 
nicotine, only the Control groups were used in the analyses as this was their first 
experience with nicotine.  Mecamylamine was found to differentially block the 
hypoactive effects of nicotine (Figure 9).  Repeated measures revealed a significant main 
effect for 5-min bins, F(11, 308) = 40.03, p<.001, and a main effect of rearing condition, 
F(2, 28) = 11.40, p<.001.  An interaction effect was also found between 5-min bins X 
rearing condition, F(22, 308) = 1.72, p<.05, and a 5-min bins X mecamylamine treatment 
interaction, F(11, 308) = 20.46, p<.001.   
 Mecamylamine was found to block the hypoactive effects of nicotine during the 
first 15-min of the testing session.  IC rats treated with mecamylamine were found to 
have significantly greater locomotor activity than IC-Saline rats during bin 1, F(1, 28) = 
11.43, p<.001, and bin 2, F(1, 28) = 30.17, p<.001.  SC-Mecamylamine rats were found 
to have significantly greater locomotor activity than SC-Saline rats during bin 1, F(1, 28) 
= 19.55, p<.001, bin 2, F(1, 28) = 12.42, p<.001, and bin 3, F(1, 28) = 19.68, p<.001.  
EC-Mecamylamine rats were observed to display significantly greater locomotor activity 
than EC-Saline rats during bin 1, F(1, 28) = 14.67, p<.001, and bin 2, F(1, 28) = 12.62, 
p<.001.   
 Saline treated rats were not found to significantly differ between rearing 
conditions, however, EC rats treated with mecamylamine were found to have 
significantly less locomotor activity from IC and SC rats (Figure 10).  Early in the 
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session, EC rats significantly differed from SC rats during bin 1, F(1, 28) = 11.43, 
p<.001, and bin 3, F(1, 28) = 16.55, p<.001.  Later in the session, EC rats significantly 
differed from IC rats during bin 5, F(1, 28) = 19.45, p<.001, bin 6, F(1, 28) = 12.23, 
p<.001, and bin 7, F(1, 28) = 13.99, p<.001 (Figure 9B).   
Discussion 
 
 This study examined the effects of differential rearing on nicotine-induced 
conditioned hyperactivity and sensitization.  Rats raised in an enriched environment 
appear to be less sensitive to the locomotor effects of nicotine than both rats raised in an 
impoverished and social environment while IC rats appear to be most sensitive to 
nicotine-associated contextual cues.  In addition, this study also examined the effects of 
mecamylamine, a nonselective nAChR antagonist, on conditioned hyperactivity and 
sensitization in rats differentially reared. Although conditioned hyperactivity and 
sensitization was observed in all three rearing conditions, mecamylamine treatment was 
found to differentially affect EC, SC, and IC rats.  Of particular interest was the finding 
that mecamylamine blocked conditioned hyperactivity in only EC and SC rats.  These 
results suggest conditioned hyperactivity is, in part, mediated by neural nACh receptors 
and that environmental enrichment may alter these receptors. 
In the current study, repeated nicotine administration was found to induce a 
period of hypoactivity followed by hyperactivity.  Across repeated nicotine injections, 
sensitization was found to develop to the hyperactivity.  These results are consistent with 
previous research examining the locomotor effects of nicotine administration (Benwell & 
Balfour, 1992; Clarke & Kumar, 1983; Stolerman, Fink, & Jarvik, 1973).  Furthermore, 
the present results support previous findings that IC rats develop a greater locomotor 
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response to nicotine relative to EC and SC rats (Green et al., 2003).  Rats reared in an 
impoverished environment appeared to be most sensitive to the hyperactive effects of 
nicotine in comparison to rats reared in an enriched or social environment.   
 During acquisition of conditioned hyperactivity and sensitization training 
sessions, differences in baseline activity levels in saline-treated control rats were 
observed.  These baseline differences are an inherent feature of the environmental 
manipulation (Bowling & Bardo, 1995).  Despite these baseline differences, EC, SC, and 
IC rats in the Paired group did not significantly differ during session 1 of acquisition.  
Thus, the baseline difference did not prevent observations between EC, SC, and IC rats in 
the hypoactive or hyperactive effects of nicotine. 
 One of the neuropharmacological mechanisms that may contribute to the observed 
differences between EC, SC, and IC rats in response to repeated nicotine administration 
is the DA neurotransmitter system.  The mesolimbic DA reward system is a critical 
component for the reinforcing effects of nicotine. Nicotine is thought to release DA by 
impulse-regulated vesicular exocytosis (Vizi & Lendavai, 1999).  Extracellular DA is 
transported into the presynaptic terminal by DA transporters (DAT) (Zhu, 
Apparsundaram, Bardo, & Dwoskin, 2005).  Repeated nicotine exposure facilitates 
clearance of extracellular DA in the terminal regions of the mesolimbic DA pathways 
(Hart & Ksir, 1996).  It has been shown that environment enrichment also regulates DAT 
functioning.  EC rats display decreased cell surface DAT expression in the medial 
prefrontal cortex (mPFC) (Zhu et al., 2005). Furthermore, nicotine administration (0.4 
mg/kg) has been shown to increase clearance of extracellular DA in the mPFC in EC rats, 
but not in IC rats (Zhu, Bardo, Green, Wedlund, & Dwoskin, 2007).   These results 
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suggest that the observed differences in DAT functioning in the mPFC, as result of 
enrichment, may contribute to the differences in locomotor activity between EC and IC 
rats in response to nicotine. 
The present study also examined the role that rearing environment may have on 
the contextual conditioning processes of nicotine.  Following repeated pairings of 
nicotine administration with the locomotor context, rats were found to display 
conditioned hyperactivity when saline was substituted for nicotine.  Interestingly, 
although environmental enrichment has been shown to enhance learning regarding 
contextual cues (Barbelivien et al., 2006; Woodcock & Richardson, 2000), EC rats were 
found to display significantly less conditioned hyperactivity than IC and SC rats.  
However, baseline differences were observed in Control groups.  In order to standardize 
these differences, data were transformed into z-scores.   With the use of z-score analyses, 
rats in the Paired groups were still observed to display conditioned hyperactivity, 
however, there were no observed differences between rearing groups.  Since enrichment 
has been found to improve learning and memory performance, future studies will 
examine the process of extinction of nicotine-induced hyperactivity in differentially 
reared rats. 
Similarly to conditioned hyperactivity testing, rats in the Paired group were 
observed to display sensitization relative to Control groups following a 16 day rest 
period.  IC rats showed the greatest sensitization compared to EC rats. Although baseline 
differences in activity were not observed in the Control groups, data was transformed into 
z-scores in order to make results comparable to the conditioned hyperactivity test.  Z-
score analyses yielded similar results with rats in the Paired group displaying 
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sensitization relative to Control groups. However, there was no effect of rearing condition 
in the expression of sensitization.   
When treated with the nonselective antagonist, mecamylamine, expression of 
conditioned hyperactivity was blocked in EC and SC rats. Mecamylamine has previously 
been found to block cue-induced nicotine seeking behaviors (Liu et al., 2007) and the 
rewarding effects of nicotine in conditioned place preference paradigms (Fudala et al., 
1985) suggesting that nAChRs mediate the conditioning and rewarding effects of 
nicotine. The results of the current study support the hypothesis that nAChRs may 
mediate conditioned responses to nicotine-associated cues.  Control groups treated with 
saline did not significantly differ from groups treated with mecamylamine.  Thus, it is 
likely that this suppression of conditioned hyperactivity in EC and SC rats was due to 
antagonistic effects at the nAChR sites and not due to a decrease in locomotor activity 
caused by mecamylamine.  Interestingly, only IC rats were still found to display 
conditioned hyperactivity relative to IC- Controls.  This difference between EC and SC 
rats in comparison to IC rats suggests that that rearing environment may alter nAChR 
binding.  It has been shown that IC rats have less ACh relative to EC rats, thus the 
number of receptor sites may be influenced by rearing environment (Degroot, Wolff, & 
Nomikos, 2005).   
Administration of mecamylamine during the sensitization test resulted in 
attenuation of sensitization. Mecamylamine (1.2 mg/kg) has been reported to attenuate 
nicotine sensitization (Miller et al., 2001).  The results in the present study support this 
finding.  When rats were treated with mecamylamine (1.0 mg/kg) 15-min prior to 
nicotine administration, expression of sensitization was attenuated when compared to 
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saline-treated controls.  It has been hypothesized that nAChRs mediate the processes 
involved in sensitization, however, contextual conditioning processes also play a role in 
this expression (Miller et al., 2001; Reid et al., 1996).  In a study conducted by Miller et 
al. (2001) rats were injected once a week with nicotine (0.35 mg/kg) for six weeks prior 
to sensitization testing.  In the current study, rats underwent a total of 14 conditioning 
trials prior to testing for sensitization.  Thus, it is possible that the residual activity levels 
displayed by the Paired groups above saline-treated Controls reflect conditioned 
hyperactivity to the testing chamber.  
Alternatively, in another study (Ericson, Olausson, Engel, & Soderpalm, 2000) it 
was found that following 15 daily injections of nicotine (0.35 mg/kg) mecamylamine (4.0 
mg/kg) attenuated sensitization. These results suggest there is selectivity for a high versus 
low dose of mecamylamine in the blockade of hyperactivity following chronic nicotine 
administration.  This relationship between mecamylamine dose and the number of 
nicotine pre-exposure trials will require further investigation.   
Another goal of this study was to determine if rearing condition would affect 
mecamylamine sensitivity during the hypoactive phase of acute nicotine administration.  
Previous research has shown that mecamylamine (1.0 mg/kg) blocks hypoactivity to 
nicotine in rats (Bevins & Besheer, 2001).  The results to the current study support this 
finding.  Mecamylamine (1.0 mg/kg) was found to effectively block hypoactivity 
following the first 15-min of nicotine administration.  Most interestingly, EC rats treated 
with mecamylamine displayed significantly less locomotor activity than SC rats treated 
with mecamylamine early in the 1-hr session.  Conversely, EC rats treated with 
mecamylamine displayed significantly less locomotor activity than IC rats treated with 
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mecamylamine later in the 1-hr session.  Due to nicotine’s biphasic nature, an increase in 
locomotor activity can be observed 15-min following nicotine administration (Clarke & 
Kumar, 1983).  Although mecamylamine did significantly attenuate hypoactivity 
compared to saline-treated Controls within this first 15-mins, EC rats appear to be less 
sensitive to mecamylamine during the hypoactive phase.  Furthermore, despite 
mecamylamine treatment, IC rats appear to remain most sensitive to the hyperactive 
effects of nicotine.  Taken together, these results further suggest that rearing environment 
alters nAChR binding. 
It is important to note that mecamylamine is nonselective in nAChR binding. 
Further research investigating more selective nAChR antagonists will be important for 
understanding which receptor subtypes are involved in nicotine sensitization and the 
learning of nicotine-associated cues.  For example, examination of dihydro-β-
erythroidine (DHβE), an antagonist for nicotinic receptors with the α4 β2 receptor subtype 
(Williams & Robinson, 1984), and methyllycaconitine (MLA), an α7-selective antagonist 
(Alkondon, Pereira, Wonnacott, & Albuquereque, 1992), will allow for further 
understanding of how nAChRs mediate both physiological and conditioning effects of 
nicotine. 
It has been hypothesized that nAChRs, in part, mediate the locomotor effects of 
nicotine by enhancing DA release in the NAcc (Nisell, Nomikos, & Stevenson, 1994).  It 
has been suggested that this increase in DA contributes to the conditioned locomotor 
effects of nicotine (Reid, Ho, & Berger, 1998).  Furthermore, the mPFC appears to 
contribute to conditioning associated with environmental cues paired with the drug 
(Berridge & Robinson, 1998).  Given that EC and IC rats differ in DAT expression and 
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DA clearance in response to nicotine in the mPFC (Zhu et al., 2004, 2005, 2007), future 
studies will also investigate DA antagonists in differentially reared rats. For example, 
SCH-23390, a dopamine D1 receptor antagonist has been shown to block expression of 
conditioned locomotor activity to nicotine (Bevins, Besheer, & Pickett, 2001), however, 
no studies to date have examined differential effects of SCH-23390 in rats reared in 
enriched, impoverished, and social conditions.   
Environmental enrichment alters the behavioral response to a variety of 
psychostimulants.  In response to nicotine, EC rats display lower sensitivity to the 
hyperactive effects in comparison to IC rats.  Furthermore, mecamylamine was found to 
effectively block conditioned hyperactivity in EC and SC rats, suggesting that 
environmental enrichment alters nAChR sensitivity.  However, given past research 
indicating that EC and IC rats differ in DAT functioning and DAT clearance (Zhu et al., 
2004, 2005, 2007), it is possible that these differences in differentially reared rats in 
response to nicotine are due to DA neurotransmission in the mPFC.  Regardless of the 
neurological mechanisms that mediate these responses to nicotine, taken together, the 
results of the current study indicate that environmental enrichment appears to be a 
protective factor in repeated nicotine use and relapse.   
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Figure Captions 
 
Figure 1: The mean (± S.E.M.) total distance traveled (cm) for EC, IC, and SC rats in the 
Paired, Unpaired, and Control groups during sessions 1-10 of acquisition.  Asterisks (*) 
denote a significant difference (p<.001) between IC- and SC-Paired from IC- and SC- 
Control groups. Carrot signs (^) indicate a significant difference between EC-Paired and 
EC-Control groups (p<.001). 
 
Figure 2: Panel A shows the mean (± S.E.M.) total distance traveled (cm) for EC, IC, and 
SC rats in the Paired groups during sessions 1-10 of acquisition. Panel B displays the 
mean total distance traveled (cm) for EC, IC, and SC rats in the Unpaired and Control 
groups.  Asterisks (*) denote a significant difference between IC and EC rats.  Numerical 
signs (#) denote a significant difference between IC and SC rats. Carrot signs (^) denote a 
significant difference between EC and SC rats (p<.001). 
 
Figure 3: Panel A shows the mean (± S.E.M.) total distance traveled (cm) for EC, IC, and 
SC rats pretreated with saline in the Paired, Unpaired, and Control groups during the 
conditioned hyperactivity test.  Panel B displays the mean total distance traveled (cm) for 
EC, IC, and SC rats pretreated with mecamylamine (1.0 mg/kg) in the Paired, Unpaired, 
and Control groups.  Asterisks (*) denote a significant difference between Paired and 
Control groups. Numerical signs (#) denote a significant difference in EC-Paired rats 
from IC- and SC-Paired rats.  Carrot signs (^) indicate a significant difference between 
EC-Unpaired and IC-Unpaired groups. Open Circles (    ) indicate a significant difference 
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in EC-Control rats from IC- and SC-Controls (p<.01). Open squares (    ) indicate a 
significant difference between IC-Paired and IC-Unpaired rats (p<.01) 
 
Figure 4: Panel A displays the mean (1 ± S.E.M.) z-score for EC, IC, and SC rats 
pretreated with saline in the Paired, Unpaired, and Control groups during the conditioned 
hyperactivity test.  Panel B shows the mean z-score for EC, IC, and SC rats pretreated 
with mecamylamine (1.0 mg/kg) in the Paired, Unpaired, and Control groups.  Asterisks 
(*) denote a significant difference between Paired and Control groups (p<.01). 
 
Figure 5: The mean (± S.E.M.) total distance traveled (cm) for EC, IC, and SC rats in the 
Paired, Unpaired, and Control groups during sessions 1-4 of sensitization training.  
Asterisks (*) denote a significant difference (p<.001) between Paired and Control groups. 
 
Figure 6: Panel A shows the mean (± S.E.M.) total distance traveled (cm) for EC, IC, and 
SC rats in the Paired groups during sessions 1-4 of sensitization training. Panel B 
displays the mean total distance traveled (cm) for EC, IC, and SC rats in the Unpaired 
and Control groups.  Asterisks (*) denote a significant difference between EC and IC rats 
(p<.001). Carrot signs (^) denote a significant difference between EC and SC rats 
(p<.001).  Numerical signs (#) denote a significant difference between IC and SC rats 
(p<.01).  
 
Figure 7: Panel A shows the mean (± S.E.M.) total distance traveled (cm) for EC, IC, and 
SC rats pretreated with saline in the Paired, Unpaired, and Control groups during the 
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sensitization test.  Panel B displays the mean total distance traveled (cm) for rats 
pretreated with mecamylamine (1.0 mg/kg) or saline during the sensitization test. 
Panel C displays the mean total distance traveled (cm) for EC, IC, and SC rats pretreated 
with mecamylamine (0.1 mg/kg) in the Paired, Unpaired, and Control groups.  Asterisks 
(*) denote a significant difference between Paired and Control groups (p<.05). Carrot 
signs (^) indicate a significant difference between Unpaired and Control groups (p<.05).  
Numerical signs (#) denote a significant difference in EC-Paired rats from IC-Paired rats 
(7A) and SC-Paired rats (7C; p<.01).  Greater than signs (>) denote a significant 
difference between mecamylamine treatment and saline treatment for Paired groups 
(p<.001).  Less than signs (<) denote a significant difference between Paired and 
Unpaired groups (p<.05).  Open Circles (    ) indicate a significant difference in EC-
Unpaired rats from IC- and SC- Unpaired rats (p<.01).  Open squares (     ) indicate a 
significant difference between EC-Control and IC-Control rats (p<.01). 
 
Figure 8: Panel A displays the mean (1 ± S.E.M.) z-score for EC, IC, and SC rats 
pretreated with saline in the Paired, Unpaired, and Control groups during the sensitization 
test.  Panel B shows the mean z-score for EC, IC, and SC rats pretreated with 
mecamylamine (1.0 mg/kg) in the Paired, Unpaired, and Control groups.  Asterisks (*) 
denote a significant difference between Paired and Control groups. Carrot signs (^) 
denote a significant difference between Paired and Unpaired groups (p<.01). 
  
Figure 9: The mean (± S.E.M.) total distance traveled (cm) for EC, IC, and SC rats 
pretreated with mecamylamine (1.0 mg/kg) or saline in the Control groups across 5-min 
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bins during the sensitization test.  Asterisks (*) indicate a significant difference between 
mecamylamine treated rats from saline treated rats (p<.001). 
 
Figure 10: The mean (± S.E.M.) total distance traveled (cm) for EC, IC, and SC rats 
pretreated with mecamylamine (1.0 mg/kg) in the Control groups across 5-min bins 
during the sensitization test.  Asterisks (*) indicate a significant difference between IC 
and EC rats.  Numerical signs (#) indicate a significant difference between SC and EC 
rats (p<.001). 
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